Showing results (311-320 of 374) with videos related to
Sort By:
Pageof 38
Breast Cancer : Basic and Clinical Research|April 26, 2019
Using the Dermatology Life Quality Index to Assess How Breast Radiodermatitis Affects Patients' Quality of LifeLaura Curr Beamer, Marcia GrantBreast Cancer : Basic and Clinical Research|August 6, 2020
Outcome of Everolimus-Based Therapy in Hormone-Receptor-Positive Metastatic Breast Cancer Patients After Progression on PalbociclibAjay Dhakal, Roby Antony Thomas, Ellis G Levine, et al.Breast Cancer : Basic and Clinical Research|July 9, 2020
Neratinib-Induced Duodenal Ulcer: A Case ReportBahar Moftakhar, Prakash Kharel, Sujan Niraula, et al.Breast Cancer : Basic and Clinical Research|April 5, 2021
Emerging Therapeutic Drugs in Metastatic Triple-Negative Breast CancerÉlia Cipriano, Alexandra MesquitaBreast Cancer : Basic and Clinical Research|April 3, 2023
Risk of Breast Cancer Progression after Treatment in the Western Region of Saudi ArabiaMajed Ramadan, Rwiah Alsiary, Noor Alsaadoun, et al.Breast Cancer : Basic and Clinical Research|May 14, 2023
Frequency of Hepatic Metastatic Disease in Patients with Stage IV Breast Cancer Is Similar for Steatotic and Non-Steatotic LiversAdeel Haq, Tyler J Fraum, Yu Tao, et al.Breast Cancer : Basic and Clinical Research|April 15, 2021
Intraoperative Evaluation of Resection Margins in Breast-Conserving Surgery for In Situ and Invasive Breast CarcinomaCaroline Koopmansch, Jean-Christophe Noël, Calliope Maris, et al.Breast Cancer : Basic and Clinical Research|March 22, 2013
ER, PR, HER2, Ki-67 and CK5 in Early and Late Relapsing Breast Cancer-Reduced CK5 Expression in MetastasesKristiina Joensuu, Marjut Leidenius, Mia Kero, et al.Breast Cancer : Basic and Clinical Research|May 11, 2011
Growth factor receptors and apoptosis regulators: signaling pathways, prognosis, chemosensitivity and treatment outcomes of breast cancerSiddik Sarkar, Mahitosh MandalBreast Cancer : Basic and Clinical Research|July 28, 2011
Delphinidin Inhibits HER2 and Erk1/2 Signaling and Suppresses Growth of HER2-Overexpressing and Triple Negative Breast Cancer Cell LinesTuba Ozbay, Rita NahtaPageof 38